AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA TREATED WITH LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION

被引：6

作者：

MELONI, G

ANDRIZZI, C

VIGNETTI, M

GIRELLI, G

MANDELLI, F

机构：

来源：

BLOOD | 1995年 / 86卷 / 02期

关键词：

D O I：

10.1182/blood.V86.2.837.bloodjournal862837

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：837 / 838

页数：2

共 6 条

[1] EXTENDED CONTINUOUS INFUSION LOW-DOSE RECOMBINANT INTERLEUKIN-2 IN ADVANCED CANCER - PROLONGED IMMUNOMODULATION WITHOUT SIGNIFICANT TOXICITY [J].

CALIGIURI, MA ;

MURRAY, C ;

SOIFFER, RJ ;

KLUMPP, TR ;

SEIDEN, M ;

COCHRAN, K ;

CAMERON, C ;

ISH, C ;

BUCHANAN, L ;

PERILLO, D ;

SMITH, K ;

RITZ, J .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (12) :2110-2119

[2]

CALIGIURI MA, 1993, SEMIN ONCOL, V20, P3

[3]

MELONI G, 1994, BLOOD, V84, P2158

[4]

MERTELSMANN R, 1984, J BIOL RESP MODIF, V4, P483

[5] THE IL-2 RECEPTOR COMPLEX - ITS STRUCTURE, FUNCTION, AND TARGET GENES [J].

MINAMI, Y ;

KONO, T ;

MIYAZAKI, T ;

TANIGUCHI, T .

ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 :245-268

[6] INTERLEUKIN-2 - INCEPTION, IMPACT, AND IMPLICATIONS [J].

SMITH, KA .

SCIENCE, 1988, 240 (4856) :1169-1176

← 1 →